Peter DeYoung is the CEO of Piramal Global Pharma, Piramal Pharma Limited, and a member of the Piramal Pharma Limited Board. In his current role, Mr. DeYoung is responsible for steering strategy and driving profitable growth of the businesses. He has also previously handled leadership mandates as the CEO of Piramal Critical Care and President of Piramal Life Sciences.
Prior to Piramal Pharma, Mr. DeYoung worked in various investing and consulting roles in healthcare across the USA, Europe, and India. After graduation, he joined McKinsey & Company in New York, working on projects for pharmaceutical and medical device companies. He was part of the Global Health Initiative at the World Economic Forum (WEF) in Geneva, Switzerland. Post his stint with WEF, Mr. DeYoung returned to McKinsey, first in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practices. He played a role in significant transactions across a broad spectrum of industry sectors at McKinsey.
After McKinsey, he joined the Blackstone Group’s Private Equity Division in Mumbai.
Mr. DeYoung holds a Bachelor of Science Degree in Engineering from Princeton University, graduating summa cum laude, before completing his Master’s in Business Administration from Stanford University, where he was an Arjay Miller Scholar.